Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

European Innovation Council · Running

SMARTHEAL Smart Implant for Magnetic Anastomotic Healing and Leakage Evaluation

Coordinator
The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin, Ireland
Runs
1 May 2025 to 31 October 2027
Status
Running
EU funding
€2.5m
Total cost
—
Partners
4 organisations in 3 countries
Type
European Innovation Council
Grant agreement
101214689

What the project is doing

In the project's own words, from its summary on CORDIS.

Colorectal cancer affects over 1.93 million people worldwide each year. In most cases, surgery to remove the tumour is necessary, and intestinal continuity is restored through an anastomosis. However, a serious complication, known as an anastomotic leak, occurs in up to 20% of procedures. This complication is associated with high mortality rates, frequent re-interventions, prolonged hospital stays, increased healthcare costs, and a reduced quality of life.

Despite decades of research, the incidence of anastomotic leaks remains high, largely due to poor healing and delayed recognition. Leveraging outcomes from the FET Open project '5D NanoPrinting', and EIC Project 'IV-Lab', Trinity College Dublin and the Istituto Italiano di Tecnologia, in collaboration with Plio Surgical and Amsterdam UMC, aim to integrate the results of micro-sensor and nano-printing technologies into a disruptive smart magnetic anastomosis implant.

This innovative implant will offer both healing and sensing capabilities, monitoring physical and chemical parameters that signal inflammation and edema at the anastomosis site. The SMARTHEAL project will advance this technology from TRL 3 to TRL 6 by embedding micro-sensors within the implant to detect key markers of anastomotic leaks. These sensors will be integrated with wireless electronics to transmit real-time data on healing biomarkers, with the implant’s accuracy demonstrated in pre-clinical models.

SMARTHEAL represents a groundbreaking advancement, being the first implant to simultaneously enhance healing and enable early leak detection. This innovation has the potential to significantly improve surgical outcomes and reduce healthcare costs globally. It offers a substantial commercial opportunity for Plio Surgical, which aims to undertake the clinical and regulatory activities to bring this technology to market.

Topics

Who is involved

OrganisationCityCountryRole
The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinDublinIrelandCoordinator
Plio Surgical LimitedMalahideIrelandParticipant
Fondazione Istituto Italiano Di TecnologiaGenovaItalyParticipant
Stichting Amsterdam UmcAmsterdamNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI